LataMed AI is trading 15.67% up now at $0.46 as investors continue reacting to its August 19 announcement that its mobile healthcare application entered final testing ahead of planned Apple App Store and Google Play submissions.
- Management expects submissions in the coming weeks, though platform approval remains conditional.
- No separate August 21 announcement was identified, suggesting speculative continuation of the recent company-specific catalyst.